🔗 Permalink

Inventor profile of:

John C. BELL

City:

Ottawa

Country:

Canada

Published Applications:

Last publication date:

2024-07-11

Top Assignees for applications by John C. BELL

The entities that hold a legal rights for patent applications filed by inventor BELL John C.:

OTTAWA HOSPITAL RESEARCH INSTITUTE 6 Ottawa, Canada
OTTAWA HOSPITAL RESEARCH INSTITUTE 6 Ottawa, ON Canada
Wellstat Biologics Corporation 4 Gaithersburg, MD United States
TURNSTONE BIOLOGICS CORP. 3 La Jolla, CA United States
TURNSTONE BIOLOGICS CORP. 3 New York, NY United States
TURNSTONE LIMITED PARTNERSHIP 2 TORONTO, Canada
Ottawa Hospital Research Institute 2 Ottawa, Ontario, Canada
ROBARTS RESEARCH INSTITUTE 1 London, Ontario, Canada
UNIVERSITY OF OTTAWA 1 Ottawa, ON Canada
Children's Hospital of Eastern Ontario Research Institute Inc. 1 Ottawa, Canada
UNIVERSITY OF OTTAWA 1 Ottawa, Canada
OTTAWA HEALTH RESEARCH INSTITUTE 1 San Francisco, CA United States
OTTAWA HEALTH RESEARCH INSTITUTE 1 Ottawa, ON Canada
CHILDREN'S HOSPITAL OF EASTERN ONTARIO RESEARCH INSTITUTE INC. 1 Ottawa, ON Canada
ROBARTS RESEARCH INSTITUTE 1 London, Canada

Recent patent applications by BELL John C.

John C. BELL from Ottawa, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-11

US20240229069A9

Chemistry; metallurgy

MODIFIED ORTHOPOXVIRUS VECTORS

#2 | 2024-04-25

US20240132913A1

Chemistry; metallurgy

MODIFIED ORTHOPOXVIRUS VECTORS

#3 | 2023-01-26

US20230022757A1

Chemistry; metallurgy

MODIFIED VACCINIA VECTORS

#4 | 2022-12-01

US20220380799A1

Chemistry; metallurgy

MODIFIED ORTHOPOXVIRUS VECTORS

#5 | 2022-02-24

US20220056480A1

Chemistry; metallurgy

MODIFIED ORTHOPOXVIRUS VECTORS

#6 | 2020-12-17

US20200392535A1

Chemistry; metallurgy

Modified orthopoxvirus vectors

#7 | 2020-12-10

US20200385758A1

Chemistry; metallurgy

MODIFIED VACCINIA VECTORS

#8 | 2018-10-25

US20180305345A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR ENHANCING ONCOLYTIC VIRUS EFFICACY

#9 | 2015-10-01

US20150275185A1

Chemistry; metallurgy

Oncolytic rhabdovirus

#10 | 2012-11-01

US20120275999A1

Chemistry; metallurgy

Oncolytic rhabdovirus

#11 | 2011-08-25

US20110206640A1

Human necessities

Engineered synergistic oncolytic viral symbiosis

#12 | 2011-02-24

US20110044937A1

Human necessities

STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY

#13 | 2010-10-28

US20100272687A1

Chemistry; metallurgy

Mutant viruses and uses thereof

#14 | 2010-04-08

US20100086522A1

Human necessities

DISPARATE SUICIDE CARRIER CELLS FOR TUMOR TARGETING OF PROMISCUOUS ONCOLYTIC VIRUSES

#15 | 2009-12-24

US20090317362A1

Human necessities

Use of Myxoma virus for the therapeutic treatment of cancer and chronic viral infection

#16 | 2007-05-03

US20070098743A1

Chemistry; metallurgy

Mutant vesicular stomatitis viruses and uses thereof

#17 | 2007-03-20

US10717101

Purging of cells using viruses

#18 | 2006-11-23

US20060263333A1

Human necessities

Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection

InventorID:

1304397 ⎘